The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease

References

• Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut54, 710–717 (2005).
   PubMed Web of Science ®Google Scholar
• Savarino V, Celle G. The outcome of reflux oesophagitis: does drug-induced remission mean cure? Ital. J. Gastroenterol. Hepatol.30, 475–477 (1998).
   PubMedGoogle Scholar
• Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion51(Suppl. 1), 24–29 (1992).
   PubMed Web of Science ®Google Scholar
• Tytgat GNJ. Long-term therapy for reflux esophagitis. N. Engl. J. Med.333, 1148–1150 (1995).
   PubMed Web of Science ®Google Scholar
• Dent J, Brun J, Fendrick AM et al. An evidence-based appraisal of reflux disease management – The Genval Workshop Report. Gut44(Suppl. 2), S1–S16 (1999).
   PubMed Web of Science ®Google Scholar
• Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol.101, 1900–1920 (2006).
   PubMed Web of Science ®Google Scholar
• Modlin IM, Hunt RH, Malfetheiner P et al. ; on behalf of the Vevey NERD Consensus Group. Diagnosis and management of non-erosive reflux disease – the Vevey NERD Consensus Group. Digestion80, 74–78 (2009).
   PubMed Web of Science ®Google Scholar
• Venables TL, Newland RD, Patel AC et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of gastrooesophageal reflux disease in general practice. Scand. J. Gastroenterol.32, 965–973 (1997).
   PubMed Web of Science ®Google Scholar
• Joseph S, Hirano I. Gastroesophageal reflux disease: diagnosis. In: GERD/Dyspepsia: Hot Topics. Fass R (Ed.). Hanley & Belfus, PA, USA 41–54 (2004).
   Google Scholar
• Boyle JT. Gastroesophageal reflux disease in 2006. The imperfect diagnosis. Pediatr. Radiol.36(Suppl. 2), 192–195 (2006).
   PubMed Web of Science ®Google Scholar
• Schenk BE, Kuipers EJ, Klinkenberg-Knol EC et al. Omeprazole as a diagnostic tool in gastro-esophageal reflux disease. Am. J. Gastroenterol.92, 1997–2000 (1997).
   PubMed Web of Science ®Google Scholar
• Euler A, Byrne W. Twenty-four-hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology80, 957–961 (1981).
   PubMed Web of Science ®Google Scholar
• Richter J, Castell DO. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann. Intern. Med.97, 93–103 (1982).
   PubMed Web of Science ®Google Scholar
• Behar J, Biancani P, Sheahan D. Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology71, 9–15 (1976).
   PubMed Web of Science ®Google Scholar
• Fass R, Ofman JJ, Sampliner RE et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment. Pharmacol. Ther.14, 389–396 (2000).
   PubMed Web of Science ®Google Scholar
• Martinez SD, Malagon IB, Garewal HS et al. Non-erosive reflux disease (NERD) – acid reflux and symptom patterns. Aliment. Pharmacol. Ther.17, 537–545 (2003).
   PubMed Web of Science ®Google Scholar
• des Varannes SB, Mion F, Ducrottè P et al. Simultaneous recording of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut54, 1682–1686 (2005).
   PubMed Web of Science ®Google Scholar
• Pandolfino JE, Vela MF. Esophageal-reflux monitoring. Gastrointest. Endosc.69(4), 917–930 (2009).
   PubMed Web of Science ®Google Scholar
• Schindlbeck NE, Klauser AG, Voderholzer WA, Müller-Lissner SA. Empiric therapy for gastroesophageal reflux disease. Arch. Intern. Med.155, 1808–1812 (1995).
   PubMed Web of Science ®Google Scholar
• Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology112, 1798–1810 (1997).
   PubMed Web of Science ®Google Scholar
• Bruley des Varannes S, Levy P, Lartigue S et al. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment. Pharmacol. Ther.8, 309–314 (1994).
   PubMed Web of Science ®Google Scholar
• Fass R, Fennerty MB, Ofman JJ et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology115, 42–49 (1998).
   PubMed Web of Science ®Google Scholar
• Fass R, Ofman JJ, Sampliner RE et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment. Pharmacol. Ther.14, 389–396 (2000).
   PubMed Web of Science ®Google Scholar
• Bate CM, Riley SA, Chapman RW et al. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther.13, 59–66 (1999).
   PubMed Web of Science ®Google Scholar
• Johnsson F, Weywadt L, Solhaug JH et al. One-week omeprazole treatment in the diagnosis of gasto-oesophageal reflux disease. Scand. J. Gastroenterol.33, 15–20 (1998).
   PubMed Web of Science ®Google Scholar
• Juul-Hansen P, Ryding A, Jacobsen C et al. High-dose proton-pump inhibitors as a diagnostic test of gastro-esophageal reflux disease in endoscopic-negative patients. Scand. J. Gastroenterol.36, 806–810 (2001).
   PubMed Web of Science ®Google Scholar
• Xu G, Fang Y, Cheng N et al. Diagnostic value of omeprazole test in gastro-esophageal reflux disease. Chin. J. Dig.22, 7–10 (2002).
   Google Scholar
• des Varannes SB, Sacher-Huvelin S, Vavasseur F et al. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. World J. Gastroenterol.28, 2569–2573 (2006).
   Google Scholar
• Ho KY, Gwee KA, Khor CJ et al. Empirical treatment for the management of patients presenting with uninvestigated reflux symptoms: a prospective study in an Asian primary care population. Aliment. Pharmacol. Ther.21, 1313–1320 (2005).
   PubMed Web of Science ®Google Scholar
• Numans ME, Lau J, de Wit NJ et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann. Intern. Med.140, 518–527 (2004).
   PubMed Web of Science ®Google Scholar
• de Leone A, Tonini M, Dominici P, Grossi E, Pace F; on behalf of the EMERGE Study Group. The proton pump inhibitor test for gastroesophageal reflux disease: optimal cut-off value and duration. Dig. Liver Dis. DOI:10.1016/j.dld.2010.04.002 (2010) (Epub ahead of print).
   Google Scholar
• Dean BB, Gano AD, Knight K et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin. Gastroenterol. Hepatol.2, 656–664 (2004).
   PubMed Web of Science ®Google Scholar